A Randomized Comparison Between Intravenous and Perineural Dexamethasone for Ultrasound-Guided Infraclavicular Blocks

Phase 2

Completed

• Conditions: Infraclavicular blockDuration of motor blockadeIntravenous dexamethasonePerineural dexamethasone

• Registration Number: TCTR20150624001
• Lead Sponsor: o sponsor

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2015-06-24
• Study Completion: 2015-12-01
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 150

Inclusion Criteria

Patients undergoing upper extremity surgery (elbow and below) with
- American Society of Anesthesiologists classification 1-3
- body mass index between 18 and 35

Exclusion Criteria

- adults who are unable to give their own consent
-pre-existing neuropathy (assessed by history and physical examination)
-coagulopathy (assessed by history and physical examination and, if deemed clinically necessary, by blood work up i.e. platelets ≤ 100, or International Normalized Ratio ≥ 1.4)
-renal failure (assessed by history and physical examination and, if deemed clinically necessary, by blood work up i.e. creatinine ≥ 100)
-hepatic failure (assessed by history and physical examination and, if deemed clinically necessary, by blood work up i.e. transaminases ≥ 100)
-allergy to local anesthetics (LAs)
-pregnancy
-prior surgery in the infraclavicular region
- chronic pain syndromes requiring opioid intake at home

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Duration of the motor block within 48 hours the interval between the end of LA injection and the return of movement to hand and fingers